Advarra’s Gene Therapy Ready (GTR) global site network expands to better support and accelerate the rapidly growing number of CGT investigational new drugs through approval COLUMBIA, Md., Oct. 3, 2024 /PRNewswire/ — Advarra, the market leader in regulatory review solutions and clinical…